Annovis Bio, Inc. ANVS

Set alert

Price alert · ANVS

All alert types
1.12 USD +0.03 +3.24%

As of Nov 3, 1:26 PM ET

Bid
1.11 × 2,500
Ask
1.12 × 2,700
1.06 Day range 1.15
0.93 52-week range 5.50
YTD
-67.77%
1 year
-44.80%
Open
1.07
Prev close
1.08
Mkt cap
47.80M
Vol
429.61K
Avg vol
942.79K
EPS
-1.75
P/E
0.00
Div yield
0.00%
More statistics
Low
1.06
High
1.15
Forward P/E
-2.77
Beta
0.00
Short ratio
6.21
Inst. own
8.83%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
7.29
200-d avg
8.47
1y target
34.80

5Y chart

Chart tools
Interval

Events in this range
  • Mar 29, 2024Earnings: -1.09; estimate -1.35; surprise 19.26%
  • May 13, 2024Earnings: —; estimate -0.87; surprise —%
  • May 13, 2024Earnings: -0.72; estimate -0.87; surprise 17.24%
  • Aug 13, 2024Rating: EF Hutton · — → Buy
  • Aug 14, 2024Earnings: —; estimate -0.7; surprise —%
  • Aug 14, 2024Earnings: -0.44; estimate -0.7; surprise 37.14%
  • Aug 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 15, 2024Rating: EF Hutton · Buy → Buy
  • Oct 25, 2024Rating: Maxim Group · Hold → Buy
  • Nov 8, 2024Earnings: -0.97; estimate -0.64; surprise -51.56%
  • Nov 11, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 11, 2024Rating: D. Boral Capital · Buy → Buy
Signals (101)
NameDateAgo
MACD: Sell SignalSep 7, 20261 month ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 3, 20263 months ago
MACD: Buy SignalJul 6, 20264 months ago
SMA: BearishMay 25, 20265 months ago
SMA: BullishMay 18, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BullishMay 4, 20266 months ago
SMA: BearishJan 26, 20269 months ago
MACD: Sell SignalJan 26, 20269 months ago
SMA: BearishJan 12, 20269 months ago
RSI: OverboughtNov 24, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishOct 6, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BearishSep 22, 20251 year ago
SMA: BearishAug 18, 20251 year ago
SMA: BullishAug 11, 20251 year ago
SMA: BearishJul 28, 20251 year ago

Newest 20 of 101.

Analyst view

Consensus: buy

Buy
Price target (mean) 34.80 +3021.1% upside
Target (low)
21.00
Target (mean)
34.80
Target (high)
72.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANVS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.20-0.20 – -0.200.000.0%00.0%1
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-1.71-1.71 – -1.710.000.0%00.0%1
Next year-0.87-0.87 – -0.87-1.71+49.1%00.0%1

Upgrades and downgrades

The latest rating changes

ANVS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024D. Boral CapitalMaintainedBuyBuy
Nov 11, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 25, 2024Maxim GroupUpgradeHoldBuy
Aug 15, 2024EF HuttonMaintainedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2024EF HuttonInitiated—Buy
Jul 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 11, 2024HC Wainwright & Co.MaintainedBuyBuy
Jul 2, 2024Rodman & RenshawReiteratedBuyBuy
Jun 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 4, 2024Rodman & RenshawInitiated—Buy
May 13, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 30, 2024Canaccord GenuityMaintainedBuyBuy
Apr 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2024Brookline CapitalDowngradeBuyHold
Dec 29, 2023Canaccord GenuityInitiated—Buy
Nov 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 10, 2023Brookline CapitalInitiated—Buy
Aug 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 9, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 21, 2023HC Wainwright & Co.Reiterated—Buy
Feb 8, 2023HC Wainwright & Co.Reiterated—Buy
Sep 8, 2022HC Wainwright & Co.Initiated—Buy
May 2, 2022Ladenburg ThalmannInitiated—Buy